Search Within

Yanming Zhang

Formats
  1. Journal Article (95)
  2. Meeting Abstract (89)
  3. Research Letter (11)
  4. Review (3)
  5. Editorial (1)
Groups
  1. Department of Pathology and Laboratory Medicine (199)
  2. Department of Medicine (123)
  3. Center for Hematologic Malignancies (111)
  4. Hematologic Malignancies, Division of (107)
  5. Sloan Kettering Institute Postdocs (73)
  6. GSK Faculty (70)

More Groups

People
  1. Ahmet Dogan (58)
  2. Mikhail Roshal (58)
  3. Maria Arcila (55)
  4. Wenbin Xiao (48)
  5. Martin Tallman (33)
  6. Ross Levine (30)

More People

Years
  1. 2025 (6)
  2. 2024 (24)
  3. 2023 (29)
  4. 2022 (26)
  5. 2021 (25)
  6. 2020 (36)

More Years

Publications
  1. Blood (42)
  2. Modern Pathology (22)
  3. Laboratory Investigation (20)
  4. Blood Advances (11)
  5. Genes Chromosomes and Cancer (7)
  6. Nature Communications (6)

More Publications

Publishers
  1. American Society of Hematology (53)
  2. Nature Publishing Group (35)
  3. Nature Research (23)
  4. Elsevier Inc. (13)
  5. Wiley Blackwell (9)
  6. American Association for Cancer Research (7)

More Publishers

Results (199)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Chemotherapy signatures reveal the evolutionary history of post-melphalan myeloid neoplasm
    Meeting Abstract

    Diamond, B.; Ziccheddu, B.; Maclachlan, K.; Taylor, J.; Boyle, E.; Coffey, D.; Lu, S.; Bolli, N.; Bolton, K.; Park, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Erythroid and megakaryocytic differentiation program in JAK2-mutated acute myeloid leukemia with or without antecedent myeloproliferative neoplasm
    Meeting Abstract

    Liu, Y.; Sethi, S.; Koche, R.; Gao, Q.; Dilip, D.; Glass, J. L.; Galera, P. K.; Persaud, S.; Mishra, T.; Sun, X.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Quantitative cytogenetic analysis with karyoParser allows for more precise identification of disease biology, clonal evolution, and etiology of relapse in acute myeloid leukemia
    Meeting Abstract

    Dilip, D.; Derkach, A.; Menghrajani, K.; Goldberg, A. D.; May, H.; Klimek, V. M.; Galera, P. K.; Xiao, W.; Zhang, Y.; Elemento, O.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • The mutagenic impact of radiotherapy in multiple myeloma
    Meeting Abstract

    Diamond, B.; Poos, A. M.; Ziccheddu, B.; Maclachlan, K. H.; Zhang, Y.; Usmani, S.; Boyle, E. M.; Davies, F. E.; Morgan, G. J.; Landgren, O.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
    Meeting Abstract

    Ziccheddu, B.; Diamond, B.; Maclachlan, K. H.; Taylor, J.; Boyle, E. M.; Arango Ossa, J. E.; Jacob, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Tracking the earliest genomic events in multiple myeloma life-history
    Meeting Abstract

    Cirrincione, A.; Ziccheddu, B.; Maclachlan, K. H.; Poos, A. M.; Chojnacka, M.; Diamond, B.; Boyle, E. M.; Blaney, P.; Gagler, D.; Zhang, Y.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Genomic determinants of resistance in newly diagnosed multiple myeloma treated with targeted-immunotherapy
    Meeting Abstract

    Maura, F.; Boyle, E.; Coffey, D.; Maclachlan, K. H.; Diamond, B.; Blaney, P.; Gagler, D.; Ziccheddu, B.; Ghamlouch, H.; Wang, Y.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Fc-mediated antibody effector function, inflammation resolution and oligoclonality on TCR rearrangements predict sustained MRD negativity in newly diagnosed multiple myeloma treated with immunotherapy regimens
    Meeting Abstract

    Boyle, E. M.; Maura, F.; Coffey, D.; Maclachlan, K. H.; Diamond, B.; Ghamlouch, H.; Gagler, D.; Blaney, P.; Ziccheddu, B.; Wang, Y.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Consolidation therapy with blinatumomab improves overall survival in newly diagnosed adult patients with B-lineage acute lymphoblastic leukemia in measurable residual disease negative remission: Results from the ECOG-ACRIN E1910 Randomized phase III National Cooperative Clinical Trials Network trial
    Meeting Abstract

    Litzow, M. R.; Sun, Z.; Paietta, E.; Mattison, R. J.; Lazarus, H. M.; Rowe, J. M.; Arber, D. A.; Mullighan, C. G.; Willman, C. L.; Zhang, Y.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Clinicopathologic and molecular features associated with response to anti-HER2 therapy in endometrial cancer
    Meeting Abstract

    Shen, S.; Ma, W.; Zhou, Q.; Iasonos, A.; Zhang, Y.; Ross, D. S.; Makker, V.; Chui, M. H.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save